author-photo

Estelle Frisch-Dit-Leitz

Curie Institute

3

Papers

60

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Dual inhibition of protein kinase C and p53-MDM2 or PKC and mTORC1 are novel efficient therapeutic approaches for uveal melanoma

2016 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (3)
The mTOR inhibitor Everolimus synergizes with the PI3K inhibitor GDC0941 to enhance anti-tumor efficacy in uveal melanoma.

2016 Oncotarget
Show All
- Source
- Cite
- Save
Citations (23)
Dual inhibition of protein kinase C and p53-MDM2 or PKC and mTORC1 are novel efficient therapeutic approaches for uveal melanoma

2016 Oncotarget
Show All
- Source
- Cite
- Save
Citations (34)